Hookipa Pharma (HOOK) Stock Statistics & Valuation Metrics

Hookipa Pharma has a market cap or net worth of $21.27M. The enterprise value is -$21.16M.

Hookipa Pharma has 9,789,622 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hookipa Pharma’s return on equity (ROE) is -0.85 and return on invested capital (ROIC) is -87.83%.

The current PE Ratio of Hookipa Pharma is -0.58. Hookipa Pharma’s PEG ratio is <0.01.

In the last 12 months, Hookipa Pharma had revenue of 43.95M and earned -43.50M in profits. Earnings per share was -3.47.

In the last 12 months, operating cash flow was -52.77M and capital expenditures -98.00K, giving a free cash flow of -52.87M billion.

Hookipa Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Hookipa Pharma upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

Hookipa Pharma as a current ratio of 3.27, with Debt / Equity ratio of 1.75%

In the past 12 months, Hookipa Pharma has paid -106.00K in taxes.

Hookipa Pharma EV to EBITDA ratio is 0.33, with an EV/FCF ratio of 0.18.

Hookipa Pharma has $40.28M in cash and marketable securities with $596.00K in debt, giving a net cash position of -$39.68M billion.

Gross margin is 90.49%, with operating margin of -117.09%, and net profit margin of -98.99%.

The average price target for Hookipa Pharma is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold